Autoimmune hypothyroidism and trastuzumab therapy: a rare association

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

We report a case of a woman with a diagnosis of breast cancer who unintentionally started gaining weight, feeling tired, and constipated 44 weeks after the initiation of trastuzumab. Hypothyroidism secondary to an autoimmune thyroiditis associated with trastuzumab was diagnosed, the first case described in Portugal and the fourth case described worldwide. Our intention regarding the publication of this case report is to alert the clinicians treating people with trastuzumab that they should ask the patients about symptoms of hypothyroidism and should screen the thyroid function of the patients before, during, and after the initiation of trastuzumab.

Cite

CITATION STYLE

APA

Lopes, V., Machado, C., & Lages, A. de S. (2023). Autoimmune hypothyroidism and trastuzumab therapy: a rare association. Endocrinology, Diabetes and Metabolism Case Reports, 2023(2). https://doi.org/10.1530/EDM-22-0412

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free